Market Place
Sourcing Support
Beta Bionics Announces Closing of a $60 Million Series E Financing
13 Nov 2024 //
ACCESSWIRE
Xeris collaborates with Beta Bionics for worldwide license agreement
06 May 2024 //
ACCESSWIRE
Xeris partners with Beta Bionics for exclusive collaboration.
06 May 2024 //
BUSINESSWIRE
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts
14 Nov 2023 //
ACCESSWIRE
Beta Bionics Secures $100 Million in Series D Funding
30 Aug 2023 //
ACCESSWIRE
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin
22 Jun 2023 //
ACCESSWIRE
FDA clears Beta Bionics’ artificial pancreas system
22 May 2023 //
FIERCE BIOTECH
Beta Bionics Announces FDA Clearance of the iLet Bionic Pancreas
22 May 2023 //
ACCESSWIRE
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer
04 Jan 2023 //
GLOBENEWSWIRE
Beta Bionics Appoints Sean Saint as CEO and Board Member
15 Aug 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.